Clinical and laboratory aspects of the diagnosis and management of cutaneous and subcutaneous infections caused by rapidly growing mycobacteria

被引:0
作者
R. J. Kothavade
R. S. Dhurat
S. N. Mishra
U. R. Kothavade
机构
[1] Microbiology Lab,Department of Dermatology, Venereology and Leprology
[2] Epcor,Department of Dermatology and STD
[3] Grant Medical College and Sir JJ Group of Hospitals,Department of Dermatology
[4] LTM Medical College & LTMG Hospital,Biological Sciences
[5] Sion,undefined
[6] Venereology and Leprology,undefined
[7] TNMC and BYL Nair Charitable Hospital,undefined
[8] University of Alberta,undefined
来源
European Journal of Clinical Microbiology & Infectious Diseases | 2013年 / 32卷
关键词
Clarithromycin; Tigecycline; Drug Susceptibility Testing; Clofazimine; Cutaneous Infection;
D O I
暂无
中图分类号
学科分类号
摘要
Rapidly growing mycobacteria (RGM) are known to cause pulmonary, extra-pulmonary, systemic/disseminated, and cutaneous and subcutaneous infections. The erroneous detection of RGM that is based solely on microscopy, solid and liquid cultures, Bactec systems, and species-specific polymerase chain reaction (PCR) may produce misleading results. Thus, inappropriate therapeutic measures may be used in dermatologic settings, leading to increased numbers of skin deformity cases or recurrent infections. Molecular tools such as the sequence analyses of 16S rRNA, rpoB and hsp65 or PCR restriction enzyme analyses, and the alternate gene sequencing of the superoxide dismutase (SOD) gene, dnaJ, the 16S-23S rRNA internal transcribed spacers (ITS), secA, recA1, dnaK, and the 32-kDa protein gene have shown promising results in the detection of RGM species. PCR restriction enzyme analyses (PRA) work better than conventional methods at identifying species that are closely related. Recently introduced molecular tools such as matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), pyrosequencing, DNA chip technology, and Beacon probes–combined PCR probes have shown comparable results in the detection of various species of RGM. Closely related RGM species (e.g., Mycobacterium fortuitum, M. chelonae, and M. abscessus) must be clearly differentiated using accurate molecular techniques because their therapeutic responses are species-specific. Hence, this paper reviews the following aspects of RGM: (i) its sources, predisposing factors, clinical manifestations, and concomitant fungal infections; (ii) the risks of misdiagnoses in the management of RGM infections in dermatological settings; (iii) the diagnoses and outcomes of treatment responses in common and uncommon infections in immunocompromised and immunocompetent patients; (iv) conventional versus current molecular methods for the detection of RGM; (v) the basic principles of a promising MALDI-TOF MS, sampling protocol for cutaneous or subcutaneous lesions and its potential for the precise differentiation of M. fortuitum, M. chelonae, and M. abscessus; and (vi) improvements in RGM infection management as described in the recent 2011 Clinical and Laboratory Standards Institute (CLSI) guidelines, including interpretation criteria of molecular methods and antimicrobial drug panels and their break points [minimum inhibitory concentrations (MICs)], which have been highlighted for the initiation of antimicrobial therapy.
引用
收藏
页码:161 / 188
页数:27
相关论文
共 542 条
  • [1] Wang L(2000)Tuberculosis among aboriginal and nonaboriginal persons in British Columbia Can Respir J 7 151-157
  • [2] Noertjojo K(2011)Does directly observed therapy (DOT) reduce drug resistant tuberculosis? BMC Public Health 11 19-203
  • [3] Elwood RK(2010)Pulmonary nontuberculous mycobacterial disease: new insights into risk factors for susceptibility, epidemiology, and approaches to management in immunocompetent and immunocompromised patients Curr Infect Dis Rep 12 198-666
  • [4] Moonan PK(2007)Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997–2003 Thorax 62 661-326
  • [5] Quitugua TN(2010)Cutaneous tuberculosis after mesotherapy: report of six cases Biomedica 30 321-731
  • [6] Pogoda JM(2004)Epidemiology of cutaneous tuberculosis in Japan: a retrospective study from 1906 to 2002 Int J Dermatol 43 727-578
  • [7] Saleeb P(2006)Tropical dermatology: bacterial tropical diseases J Am Acad Dermatol 54 559-59
  • [8] Olivier KN(2010)Nontuberculous mycobacteria: opportunistic environmental pathogens for predisposed hosts Br Med Bull 96 45-746
  • [9] Marras TK(2002)Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria Clin Microbiol Rev 15 716-275
  • [10] Chedore P(1992)Epidemiology of infection by nontuberculous mycobacteria. Am Rev Respir Dis 145 271-2775